-transparent.png){kind=logo}
Serum antibodies to Epstein-Barr virus (EBV) were measured in members of twenty-nine families in which two or more first degree relatives had rheumatoid arthritis (RA). These patients were assessed clinically for activity of disease and their treatment recorded. A higher proportion of seropositive individuals was found among patients and affected kindred than among the non-affected groups. Antibody titres to Viral Capsid Antigen (VCA) tended to be higher in patients and affected kindred. In those individuals in whom antibody to Early Antigen (EA) was present there was a lower titre of antibody to Epstein-Barr Nuclear Antigen (ENBA). The results suggest that an immunoregulatory defect may exist in some patients with RA which allows for enhanced expression of EBV.
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
January 1976,
Sovetskaia meditsina,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
January 1981,
Springer seminars in immunopathology,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
January 1983,
Rheumatology international,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
November 1979,
Proceedings of the National Academy of Sciences of the United States of America,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
December 1985,
Clinics in rheumatic diseases,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
February 1982,
Journal of clinical microbiology,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
April 1981,
The Journal of clinical investigation,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
June 1977,
British journal of cancer,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
February 2018,
Scientific reports,
M McDermott, and
M Molloy, and
J Buckley, and
J Greally
June 1998,
Revue du rhumatisme (English ed.),
